Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

5.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
5.0K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

6.4K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.4K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

4.2K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.2K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

2.7K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.7K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

4.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world evidence on infection risk in multiple myeloma treated with BiTEs and CAR-T cells: a meta-analysis.

Experimental hematology & oncology·2026
Same author

Eosinophil-linked pulmonary circulation in EGPA Improves under anti-IL-5/R therapy: A longitudinal study.

European journal of internal medicine·2026
Same author

Inborn errors of immunity: a structured model for paediatric-to-adult transition of care.

Frontiers in immunology·2026
Same author

Navigating primary and secondary immunodeficiency intersections: how to find IEI hidden within SID.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same author

Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohort.

Lupus science & medicine·2026
Same author

Real-world incidence of severe infections in multiple myeloma patients receiving bispecific antibodies: a meta-analysis.

Annals of hematology·2026
Same journal

Sclerostin silencing in human umbilical cord mesenchymal stem cells enhances bone regeneration <i>via</i> Wnt pathway activation.

World journal of stem cells·2026
Same journal

Targeting mitochondrial quality control in osteoarthritis with GrpE-like 1-loaded synovial mesenchymal stromal/stem cell small extracellular vesicles.

World journal of stem cells·2026
Same journal

Epiregulin enhances periodontal tissue regeneration by promoting bone marrow mesenchymal stem cell functions under inflammatory niches.

World journal of stem cells·2026
Same journal

Correction to "Synergism of calycosin and bone marrow-derived mesenchymal stem cells to combat podocyte apoptosis to alleviate adriamycin-induced focal segmental glomerulosclerosis".

World journal of stem cells·2026
Same journal

GATA2 deficiency exacerbates chronic liver injury <i>via</i> disrupting hepatocyte death-regeneration balance: Clinical, histopathological, and molecular evidence.

World journal of stem cells·2026
Same journal

Therapeutic applications of mesenchymal stem cell-derived extracellular vesicles in pain management: A narrative review of emerging evidence and future directions.

World journal of stem cells·2026
See all related articles

Related Experiment Video

Updated: Apr 18, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.9K

Identify multiple myeloma stem cells: Utopia?

Ilaria Saltarella1, Aurelia Lamanuzzi1, Antonia Reale1

  • 1Ilaria Saltarella, Aurelia Lamanuzzi, Antonia Reale, Angelo Vacca, Roberto Ria, Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine "G. Baccelli", University of Bari "Aldo Moro" Medical School, Policlinico, I-70124 Bari, Italy.

World Journal of Stem Cells
|January 27, 2015
PubMed
Summary
This summary is machine-generated.

Multiple myeloma cancer stem cells (CSCs) are key to disease progression and drug resistance. Understanding these distinct cell subpopulations and their bone marrow microenvironment interactions is crucial for developing new treatments.

Keywords:
Bone marrow microenvironmentCancer stem cellsMultiple myelomaStem cells nicheStemness

More Related Videos

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.6K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.2K

Related Experiment Videos

Last Updated: Apr 18, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.9K
Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.6K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.2K

Area of Science:

  • Hematologic Oncology
  • Cancer Stem Cell Biology
  • Tumor Microenvironment Research

Background:

  • Multiple myeloma (MM) is an incurable plasma cell malignancy, despite therapeutic advancements.
  • Cancer stem cells (CSCs) are implicated in various cancers, with their role in MM being investigated.
  • The existence of distinct MM CSC subpopulations, including clonotypic B and non-B cells, is postulated.

Purpose of the Study:

  • To review and focus on distinct clonotypic subpopulations within multiple myeloma.
  • To examine the role of these subpopulations in the development and sustenance of MM.
  • To explore the interaction between MM CSCs and the bone marrow microenvironment.

Main Methods:

  • Review of existing literature on multiple myeloma cancer stem cells.
  • Analysis of the proposed mechanisms of CSC self-renewal, survival, and drug resistance.
  • Examination of the role of the bone marrow microenvironment and stemness signaling pathways (Hedgehog, Wnt, Notch).

Main Results:

  • The bone marrow microenvironment supports MM CSCs through specialized niches, promoting self-renewal, survival, and drug resistance.
  • Interactions between MM CSCs and niches involve adhesion molecules and signaling pathways crucial for stemness.
  • MM CSCs are hypothesized to be central to the multi-step development of drug resistance in multiple myeloma.

Conclusions:

  • Distinct clonotypic subpopulations of MM CSCs likely drive disease progression.
  • The bone marrow microenvironment plays a critical role in nurturing MM CSCs and conferring drug resistance.
  • Further research into MM CSCs and their niche interactions is essential for overcoming therapeutic challenges.